chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Chills, Dizziness, Dyspnoea
Clinical narrative: Difficulty breathing; Swelling a bit of my face; Pressure over chest; Dizziness; Weakness; Injection site pain; Injection site itchy; Tiredness; Headache; Muscle pain; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Apr2021 at 13:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included supplements (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 13:30 as a single dose for COVID-19 immunisation. On 06Apr2021, the patient experienced difficulty breathing, swelling a bit of my face, pressure over chest, dizziness and weakness, injection site pain and itchy, tiredness, headache, muscle pain, fever and chills (subsided). Therapeutic measures were not taken as the result of adverse events. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events difficulty breathing, swelling a bit of my face, pressure over chest, dizziness and weakness, injection site pain and itchy, tiredness, headache, muscle pain was recovering at the time of this report while that of the events fever and chills was recovered on an unknown date in Apr2021.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pruritus, Myalgia, Pyrexia
Clinical narrative: Difficulty breathing; Swelling a bit of my face; Pressure over chest; Dizziness; Weakness; Injection site pain; Injection site itchy; Tiredness; Headache; Muscle pain; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Apr2021 at 13:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included supplements (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 13:30 as a single dose for COVID-19 immunisation. On 06Apr2021, the patient experienced difficulty breathing, swelling a bit of my face, pressure over chest, dizziness and weakness, injection site pain and itchy, tiredness, headache, muscle pain, fever and chills (subsided). Therapeutic measures were not taken as the result of adverse events. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events difficulty breathing, swelling a bit of my face, pressure over chest, dizziness and weakness, injection site pain and itchy, tiredness, headache, muscle pain was recovering at the time of this report while that of the events fever and chills was recovered on an unknown date in Apr2021.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Vaccination site pain
Clinical narrative: Difficulty breathing; Swelling a bit of my face; Pressure over chest; Dizziness; Weakness; Injection site pain; Injection site itchy; Tiredness; Headache; Muscle pain; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Apr2021 at 13:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included supplements (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 13:30 as a single dose for COVID-19 immunisation. On 06Apr2021, the patient experienced difficulty breathing, swelling a bit of my face, pressure over chest, dizziness and weakness, injection site pain and itchy, tiredness, headache, muscle pain, fever and chills (subsided). Therapeutic measures were not taken as the result of adverse events. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events difficulty breathing, swelling a bit of my face, pressure over chest, dizziness and weakness, injection site pain and itchy, tiredness, headache, muscle pain was recovering at the time of this report while that of the events fever and chills was recovered on an unknown date in Apr2021.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Heart rate, Myalgia
Clinical narrative: headache; tiredness; injection site pain; muscle pain; fever of 99.9; mild tachycardia; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 33-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8734, Expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 07Apr2021 at 13:30 as dose 2, single for covid-19 immunization. Medical history included asthma, persistent depressive disorder from an unknown date and unknown if ongoing and no known allergies. If Covid prior vaccination, if Covid tested post vaccination and if other vaccine in four week was reported as no. Concomitant medications included bupropion (BUPROPION), ibuprofen (ADVIL 12 HOUR), azithromycin (AZO), turnera diffusa leaf (DAMIANA LEAVES) and probiotics taken for an unspecified indication, start and stop date were not reported (for all concomitant medications). On 08Apr2021, the patient experienced headache, tiredness, injection site pain, muscle pain, fever of 99.9, but also have mild tachycardia (heart rate was between 90-105 just laying in bed or sitting in a chair) from app. This started day after injection, not the day of. The patient underwent lab tests and procedures which included body temperature: 99.9 on 08Apr2021 and heart rate: between 90-105 on 08Apr2021 laying in bed or sitting in a chair. The patient did not received any treatments for adverse events. The clinical outcome of events was reported as not recovered.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tachycardia, Vaccination site pain
Clinical narrative: headache; tiredness; injection site pain; muscle pain; fever of 99.9; mild tachycardia; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 33-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8734, Expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 07Apr2021 at 13:30 as dose 2, single for covid-19 immunization. Medical history included asthma, persistent depressive disorder from an unknown date and unknown if ongoing and no known allergies. If Covid prior vaccination, if Covid tested post vaccination and if other vaccine in four week was reported as no. Concomitant medications included bupropion (BUPROPION), ibuprofen (ADVIL 12 HOUR), azithromycin (AZO), turnera diffusa leaf (DAMIANA LEAVES) and probiotics taken for an unspecified indication, start and stop date were not reported (for all concomitant medications). On 08Apr2021, the patient experienced headache, tiredness, injection site pain, muscle pain, fever of 99.9, but also have mild tachycardia (heart rate was between 90-105 just laying in bed or sitting in a chair) from app. This started day after injection, not the day of. The patient underwent lab tests and procedures which included body temperature: 99.9 on 08Apr2021 and heart rate: between 90-105 on 08Apr2021 laying in bed or sitting in a chair. The patient did not received any treatments for adverse events. The clinical outcome of events was reported as not recovered.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: High fever for two days then low grade fever for three days, shooting pains in fingers, left arm and left side near armpit for one day, tiredness; High fever for two days then low grade fever for three days, shooting pains in fingers, left arm and left side near armpit for one day, tiredness; High fever for two days then low grade fever for three days, shooting pains in fingers, left arm and left side near armpit for one day, tiredness; High fever for two days then low grade fever for three days, shooting pains in fingers, left arm and left side near armpit for one day, tiredness; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant adult female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 06Apr2021 at 17:15 (age at vaccination) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and hypothyroidism. The patient previously took Amoxicillin, Erythromycin and Bactrim and experienced drug allergy to Amoxicillin, Erythromycin and Bactrim. Concomitant medications taken within two weeks prior to vaccination included levothyroxine sodium (LEVOXYL), cetirizine hydrochloride (ZYRTEC), rosuvastatin calcium (CRESTOR), mometasone furoate (NASONEX) and azelastine (MANUFACTURER UNKNOWN) all from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Mar2021 at 17:15 (age at vaccination) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 07:00, the patient experienced high fever for two days then low grade fever for three days from 09Apr2021. On 07Apr2021 at 07:00, the patient also experienced shooting pains in fingers, left arm and left side near armpit for one day, tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events high fever for two days was resolved on 09Apr2021, then low grade fever for three days was resolved on 11Apr2021, shooting pains in fingers, left arm and left side near armpit for one day was resolved on 08Apr2021 and of tiredness was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Neurological examination
Clinical narrative: Her left arm went numb; then like 20 minutes later whole left side of her body went numb; it didn't go away, it got worst; This is a spontaneous report from a non-contactable consumer (Parent). This is the second out of two cases.     A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8733), via intramuscular route of administration on 01Apr2021 at 18:30 (at the age of 25-year-old), as dose 1, single in left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 01Apr2021 at 18:45, 15 minutes after the first dose of vaccine, the patient's left arm went numb; then like 20 minutes later whole left side of her body went numb; it didn't go away, it got worst. Patient visited emergency room and did a basic neurological exam to make sure that she didn't have a stroke. But it wasn't a stroke. The event didn't go away, it got worst. The next morning, the patient visited doctor. Doctor said it was not a stroke. Patient did not take any treatment for the adverse event. The patient underwent lab test and procedure which included neurological examination: not stroke, on 01Apr2021. The clinical outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspnoea, Headache, Pyrexia
Clinical narrative: Fever of 102F; Chills; Headache; Ringing ears; Trouble breathing; This is a spontaneous report from a contactable other healthcare professional, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the  left arm on 10Apr2021 at 16:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included naproxen (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration  on an unknown date as a single dose for COVID-19 immunisation. On 11Apr2021 at 13:00, the patient experienced fever of 102 Fahrenheit, chills, headache, ringing ears and had trouble breathing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of fever of 102 Fahrenheit, chills, headache, ringing ears and trouble breathing were not resolved at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Fever of 102F; Chills; Headache; Ringing ears; Trouble breathing; This is a spontaneous report from a contactable other healthcare professional, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the  left arm on 10Apr2021 at 16:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included naproxen (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration  on an unknown date as a single dose for COVID-19 immunisation. On 11Apr2021 at 13:00, the patient experienced fever of 102 Fahrenheit, chills, headache, ringing ears and had trouble breathing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of fever of 102 Fahrenheit, chills, headache, ringing ears and trouble breathing were not resolved at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: Nauseous for 2 days after; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06Apr2021 at 14:30 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, latex allergy, allergy to bananas, cucumber and seasonal allergy. Concomitant medications included cetirizine hydrochloride (ZYRTEC), ethinylestradiol; drospirenone (YASMIN 28), amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL), colecalciferol (VITAMIN D 3) and d-mannose (MANUFACTURER UNKNOWN); all taken from an unknown date for unknown indications. The patient previously took the first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 12Mar2021 at 15:15 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 07Apr2021 at 00:00, the patient reported that she felt nauseous for 2 days after and experienced diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event nauseous for 2 days after was resolved on 09Apr2021 at 00:00 and the clinical outcome of the event diarrhea was resolved on an unspecified date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Urticaria
Clinical narrative: Hives/rash over several parts of body / "UrticarialHypersensitivity Reaction"; This is a spontaneous report from a contactable nurse. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK9231) via an unspecified route of administration in the left arm on 09Jan2021 at 19:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262) via an unspecified route of administration in the left arm on 30Jan2021 at 16:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. Concomitant medications included dietary supplements (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Jan2021, after the first vaccine, the patient developed areas of hives/ rash over several parts of body, not immediately but days later and became severe after the second vaccine dose. The event resulted in a visit to the doctors or other healthcare professional office/clinic visit. The patient had seen a dermatologist and an allergist and had extensive allergy testing done. On an unknown date, the patient underwent biopsy of the rash and the result was urticarial hypersensitivity reaction. Therapeutic measures were taken as a result of the event and included treatment with prednisone oral, topical steroids and antihistamines. The clinical outcome of the event hives/ rash over several parts of body was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Lymph node pain, Pain
Clinical narrative: Sore lymph nodes; Aches; Headaches; 101.6 Fever; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration in the left arm on 09Apr2021 at 13:45 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included depression. Concomitant medication included citalopram hydrobromide (CELEXA) for depression from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6204) via an unspecified route of administration in the left arm on 19Mar2021 at 13:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 09Apr2021 at 20:00, the patient experienced sore lymph nodes, aches, headaches, 101.6 fever and fatigue. On 09Apr2021 the patient underwent lab tests which include body temperature and the result was found to be 101.6 (unspecified units).The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ADVIL. The clinical outcome of sore lymph nodes, aches, headaches, 101.6 fever and fatigue was recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sore lymph nodes; Aches; Headaches; 101.6 Fever; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration in the left arm on 09Apr2021 at 13:45 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included depression. Concomitant medication included citalopram hydrobromide (CELEXA) for depression from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6204) via an unspecified route of administration in the left arm on 19Mar2021 at 13:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 09Apr2021 at 20:00, the patient experienced sore lymph nodes, aches, headaches, 101.6 fever and fatigue. On 09Apr2021 the patient underwent lab tests which include body temperature and the result was found to be 101.6 (unspecified units).The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ADVIL. The clinical outcome of sore lymph nodes, aches, headaches, 101.6 fever and fatigue was recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Tinnitus
Clinical narrative: tinnitus in both ears; started experiencing headaches; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: En6207) via an unspecified route of administration in the left arm on 17Mar2021 as a single dose for COVID-19 immunisation. Medical history included meniere's disease and vertigo. The patient had no known allergies for medications, food or other products. Concomitant medications included amlodipine besilate (AMLODIPINE BESILYATE), pravastatin sodium (PRAVASTATIN) and potassium (MANUFACTURER UNKNOWN) from unknown date and for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: En6200) via an unspecified route of administration in the arm left on 19Feb2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, 2 weeks after the last covid vaccine shot, the patient experienced headaches and tinnitus in both ears. No therapeutic measures were taken as a result of the reported events. The adverse events resulted in doctor or other healthcare professional office/clinic visit/ emergency visit. The clinical outcome of the events headaches and tinnitus in both ears was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Poor quality sleep
Clinical narrative: Severe headaches; Nauseous; Could not  sleep due to the severity of the headache; This is a spontaneous report from a contactable nurse. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the arm left on 08Mar2021 at 14:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the arm left on 29Mar2021 at 13:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 08Mar2021 since the vaccine, the patient experienced severe headaches that would not go away and make her nauseous.  She suffers from the headaches day and night and could not sleep due to the severity of the headaches. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events severe headaches, nauseous and could not sleep due to the severity of the headache was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test, Vertigo
Clinical narrative: Vertigo; Daily headaches; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the left arm on 23Feb2021 (at the age of 55-years-old) as a single dose for COVID-19 immunization. Medical history included asthma, atrial fibrillation, obesity and degenerative disc disease from unspecified date. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT) taken for an unspecified indication, start and stop date were not reported started on an unknown date for unknown indication. The patient was allergic to sulfur medication, apples and stone fruit. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021, the patient experienced vertigo and daily headaches. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included treatment with unspecified medication. On an unknown date, the patient underwent nasal swab test with unknown results. The clinical outcome of vertigo and daily headaches was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Feeling abnormal, Feeling of body temperature change, Lethargy
Clinical narrative: lethargic; hot and cold; very sore throat; brain fog; sore chest; struggling to breath; This is a spontaneous report from a contactable consumer (patient) via . This non-pregnant 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0151) via an unspecified route of administration in the left arm on 09Apr2021 at 19:30 (at 45-years-old) as a single dose for COVID-19 immunisation. Medical history included common variable immunodeficiency (CVID), mast cell activation syndrome (MCAS), mitral valve, allergy to wheat, allergy to dairy, and allergy to capsicum, all from unknown dates and unknown if ongoing. Prior to vaccination the patient had not been diagnosed with COVID-19. Concomitant medications included estradiol, loratadine (ALLERCLEAR), olive leaf, pre-biotics, and post-biotics, all from unknown dates for unknown indications. The patient previously received immunoglobulin from an unknown date for an unknown indication and experienced allergy; and previously received the first dose of BNT162B2 (lot number ER2613) in the left arm on 16Mar2021 at 14:15 (at 45-years-old) for COVID-19 immunisation. The patient reported that on 10Apr2021 at 21:30 she was struggling to breath. Her husband put her on their home nebulizer with budesonide two times and that was not helping so he administered epinephrine (EPIPEN) then followed up with 2 diphenhydramine hydrochloride (BENADRYL) and things began calming down. Today (as of 11Apr2021) the patient was lethargic, hot and cold, had very sore throat, brain fog, and sore chest. She reported that if they didn't have their own nebulizer, they would have had to call an ambulance and gone to the hospital, further reporting this was a pretty serious reaction. She stated she had Mast Cell Activation Syndrome (MCAS) and Common Variable Immune Disease (CVID) and she had not received immunoglobulins for 1.5 years so far. The events did not require hospitalization. The clinical outcomes of the events were reported as recovering. It was also reported that since vaccination the patient had not been tested for COVID-19.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: lethargic; hot and cold; very sore throat; brain fog; sore chest; struggling to breath; This is a spontaneous report from a contactable consumer (patient) via . This non-pregnant 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0151) via an unspecified route of administration in the left arm on 09Apr2021 at 19:30 (at 45-years-old) as a single dose for COVID-19 immunisation. Medical history included common variable immunodeficiency (CVID), mast cell activation syndrome (MCAS), mitral valve, allergy to wheat, allergy to dairy, and allergy to capsicum, all from unknown dates and unknown if ongoing. Prior to vaccination the patient had not been diagnosed with COVID-19. Concomitant medications included estradiol, loratadine (ALLERCLEAR), olive leaf, pre-biotics, and post-biotics, all from unknown dates for unknown indications. The patient previously received immunoglobulin from an unknown date for an unknown indication and experienced allergy; and previously received the first dose of BNT162B2 (lot number ER2613) in the left arm on 16Mar2021 at 14:15 (at 45-years-old) for COVID-19 immunisation. The patient reported that on 10Apr2021 at 21:30 she was struggling to breath. Her husband put her on their home nebulizer with budesonide two times and that was not helping so he administered epinephrine (EPIPEN) then followed up with 2 diphenhydramine hydrochloride (BENADRYL) and things began calming down. Today (as of 11Apr2021) the patient was lethargic, hot and cold, had very sore throat, brain fog, and sore chest. She reported that if they didn't have their own nebulizer, they would have had to call an ambulance and gone to the hospital, further reporting this was a pretty serious reaction. She stated she had Mast Cell Activation Syndrome (MCAS) and Common Variable Immune Disease (CVID) and she had not received immunoglobulins for 1.5 years so far. The events did not require hospitalization. The clinical outcomes of the events were reported as recovering. It was also reported that since vaccination the patient had not been tested for COVID-19.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: Parosmia; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL2964) via an unspecified route of administration in the arm left on 27Mar2021 at 09:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, seasonal allergies, COVID-19 from an unknown date in Dec2020 and stop date was unknown and anosmia for 5 days. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient previously took amoxicillin (AMOXIL) and experienced allergy. On 30Mar2021, the patient experienced parosmia. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event parosmia was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Rash
Clinical narrative: Headache; Arm ache; Fatigue; Rash; This is a spontaneous report from a contactable other healthcare professional, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 06Apr2021 at 12:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO) for unspecified indication from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 16Mar2021 at 12:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. On 07Apr2021 at 07:00 the patient experienced headache, arm ache, fatigue and rash. No therapeutic measures were taken for the events. The clinical outcome of the events headache, arm ache, fatigue and rash were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Lymphadenopathy
Clinical narrative: breast bone pain; Swollen lymph nodes on left side of breast; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 25Feb2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, first week after the second dose, the patient experienced swollen lymph nodes on the left side of breast which gradually shifted to the right side with breast bone pain at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen lymph nodes on the breasts with breast bone pain were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Tic
Clinical narrative: Muscle tics; Spasms in left eye and left point finger; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533), via an unspecified route of administration in the left arm on 01Apr2021 at 14:15 (at the age of 32-year-old), as a single dose for COVID-19 immunisation. Medical history included seizures. The patient did not have any allergies to food, medications, or other products. Concomitant medications included progesterone cream (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D) and oenothera biennis oil (PRIMROSE) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 14:30, the patient experienced muscle tics, spasms in left eye and left pointer finger. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events muscle tick/spasms in left eye and spasms left pointer finger was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Eye pruritus, Hypoaesthesia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 09:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19. The patient previously took Aspirine and experienced drug allergy. The patient did not take any medications within two weeks prior to vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 14:00, the patient experienced eyes itching and thy numbness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events eyes itching and thy numbness was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Thirst, Vaccination site pain
Clinical narrative: Severe thirst (dehydration?); Pain on injection site; Severe throbbing headache; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 28Mar2021 at 12:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient was allergic to penicillin, cherries and peaches. The patient previously took aspirin (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy on unknown dates. The patient did not receive any medication within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 16:00, the patient experienced pain on injection site, severe throbbing headache and severe thirst (Dehydration?) for 2 days following vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen (ADVIL) for every 5 hours. The clinical outcome of events pain on injection site, severe throbbing headache and severe thirst were resolved on 30Mar2021.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Gingival swelling, Hypoaesthesia
Clinical narrative: Gum swelling for a week; left arm has been numb; This is a spontaneous report from a non-contactable healthcare professional. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Jan2021 at 14:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Jan2021, the patient experienced gum swelling for a week after receiving the shot and the left arm has been numb since receiving the shot. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events gum swelling was resolved on 31Jan2021 while that of left arm numbness was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Sleep disorder
Clinical narrative: been up since 5a and it's now 6a; woke up and feeling like was in a fog; Feeling uneasy on feet; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 10:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20Mar2021 at 13:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 11Apr2021 at 05:00, the patient woke up and feeling like was in a fog and was feeling uneasy on feet, went away within 4-5 hours. It was reported that on 12Apr2021 (Monday), the patient woke up and again feeling like she was in a fog, feeling uneasy on feet. The patient had been up since 05:00 and it was 06:00 at the time of report. Therapeutic measures were not taken as a result of the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events woke up and feeling like was in a fog, feeling uneasy on feet and had been up since 05:00 and it was 06:00 at that time was not recovered at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.